These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1103 related items for PubMed ID: 19342035

  • 1. Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression.
    Cavagna M, Maldonado LG, de Souza Bonetti TC, de Almeida Ferreira Braga DP, Iaconelli A, Borges E.
    Fertil Steril; 2010 Jun; 94(1):167-72. PubMed ID: 19342035
    [Abstract] [Full Text] [Related]

  • 2. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K, Berker B, Atabekoglu CS, Sonmezer M, Cetinkaya E, Aytac R, Satiroglu H.
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [Abstract] [Full Text] [Related]

  • 3. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM, Bates GW, Robinson RD, Arthur NJ, Martin JE, Neal GS.
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [Abstract] [Full Text] [Related]

  • 4. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K.
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [Abstract] [Full Text] [Related]

  • 5. Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation.
    Malmusi S, La Marca A, Giulini S, Xella S, Tagliasacchi D, Marsella T, Volpe A.
    Fertil Steril; 2005 Aug; 84(2):402-6. PubMed ID: 16084881
    [Abstract] [Full Text] [Related]

  • 6. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F, Cobellis L, Mele D, Tassou A, Badolati B, Sorrentino S, De Lucia D, Colacurci N.
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [Abstract] [Full Text] [Related]

  • 7. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial.
    Kyrou D, Kolibianakis EM, Fatemi HM, Tarlatzis BC, Tournaye H, Devroey P.
    Fertil Steril; 2011 Nov; 96(5):1112-5. PubMed ID: 21924414
    [Abstract] [Full Text] [Related]

  • 8. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grøndahl ML, Westergaard L, Andersen CY.
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [Abstract] [Full Text] [Related]

  • 9. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN, Engmann L, DiLuigi A, Maier D, Nulsen J, Benadiva C.
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [Abstract] [Full Text] [Related]

  • 10. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM.
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [Abstract] [Full Text] [Related]

  • 11. Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a randomized, controlled trial.
    Baerwald A, Anderson P, Yuzpe A, Case A, Fluker M.
    Fertil Steril; 2012 Oct; 98(4):881-7.e1-2. PubMed ID: 22819187
    [Abstract] [Full Text] [Related]

  • 12. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
    Serafini P, Yadid I, Motta EL, Alegretti JR, Fioravanti J, Coslovsky M.
    Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
    [Abstract] [Full Text] [Related]

  • 13. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
    Humaidan P, Ejdrup Bredkjaer H, Westergaard LG, Yding Andersen C.
    Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
    [Abstract] [Full Text] [Related]

  • 14. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.
    Kolibianakis EM, Papanikolaou EG, Tournaye H, Camus M, Van Steirteghem AC, Devroey P.
    Fertil Steril; 2007 Nov; 88(5):1382-8. PubMed ID: 17445806
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
    Tesarik J, Hazout A, Mendoza-Tesarik R, Mendoza N, Mendoza C.
    Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
    [Abstract] [Full Text] [Related]

  • 16. [Clinical application of gonadotropin-releasing hormone antagonist in Chinese women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer].
    Chen SL, Yin MN, Sun L, Li H, Chen X, Song HD, He JX, Zhu L, Xing FQ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):588-90. PubMed ID: 17545062
    [Abstract] [Full Text] [Related]

  • 17. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [Abstract] [Full Text] [Related]

  • 18. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates.
    Acevedo B, Gomez-Palomares JL, Ricciarelli E, Hernández ER.
    Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344
    [Abstract] [Full Text] [Related]

  • 19. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
    Kim CH, Ahn JW, You RM, Kim SH, Chae HD, Kang BM.
    J Reprod Med; 2014 Dec; 59(1-2):63-8. PubMed ID: 24597289
    [Abstract] [Full Text] [Related]

  • 20. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB, Surrey ES, Minjarez DA, Stevens JM, Gardner DK.
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.